Jane Street’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,200
Closed -$120K 11639
2025
Q2
$120K Buy
+13,200
New +$97.1K ﹤0.01% 8871
2024
Q2
Sell
-19,100
Closed -$358K 10092
2024
Q1
$358K Sell
19,100
-5,100
-21% -$118K ﹤0.01% 7274
2023
Q4
$524K Sell
24,200
-46,400
-66% -$919K ﹤0.01% 6675
2023
Q3
$1.45M Sell
70,600
-3,700
-5% -$107K ﹤0.01% 4576
2023
Q2
$3.49M Buy
74,300
+1,400
+2% +$69.7K ﹤0.01% 3262
2023
Q1
$3.06M Sell
72,900
-27,500
-27% -$1.18M ﹤0.01% 3115
2022
Q4
$3.83M Sell
100,400
-14,000
-12% -$535K ﹤0.01% 2851
2022
Q3
$4.48M Buy
114,400
+77,600
+211% +$3M ﹤0.01% 2793
2022
Q2
$1.19M Buy
36,800
+14,600
+66% +$489K ﹤0.01% 5161
2022
Q1
$735K Buy
22,200
+9,500
+75% +$357K ﹤0.01% 6753
2021
Q4
$540K Sell
12,700
-14,800
-54% -$620K ﹤0.01% 7114
2021
Q3
$1.22M Sell
27,500
-183,300
-87% -$8.41M ﹤0.01% 5517
2021
Q2
$12M Buy
210,800
+186,800
+778% +$13.2M ﹤0.01% 1521
2021
Q1
$1.8M Sell
24,000
-32,700
-58% -$2.68M ﹤0.01% 4225
2020
Q4
$4.91M Sell
56,700
-115,100
-67% -$8.48M ﹤0.01% 2155
2020
Q3
$10.5M Buy
171,800
+52,200
+44% +$2.65M 0.01% 1181
2020
Q2
$4.97M Buy
119,600
+110,200
+1,172% +$4M ﹤0.01% 1850
2020
Q1
$270K Sell
9,400
-40,400
-81% -$2.34M ﹤0.01% 4324
2019
Q4
$3.6M Buy
49,800
+45,400
+1,032% +$5.58M 0.01% 1350
2019
Q3
$617K Buy
4,400
+2,900
+193% +$485K ﹤0.01% 3271
2019
Q2
$275K Sell
1,500
-900
-38% -$154K ﹤0.01% 4318
2019
Q1
$382K Sell
2,400
-700
-23% -$101K ﹤0.01% 3990
2018
Q4
$297K Buy
+3,100
New +$355K ﹤0.01% 4080
2016
Q3
Sell
-10,700
Closed -$322K 4453
2016
Q2
$322K Buy
+10,700
New +$357K ﹤0.01% 3237

Other funds holding SAGE